valneva chikungunya - Search News

News

Valneva Shares Tumble

Benzinga · 14h

Safety Concerns Hit Valneva As Ixchiq Chikungunya Virus Vaccine Is Suspended In US

Valneva shares fall after FDA suspends Ixchiq vaccine license citing new safety reports, raising questions over future U.S. sales and regulatory review.

MarketWatch · 16h

Valneva Shares Tumble After Chikungunya Vaccine License Suspended in U.S.

Valneva shares dropped after it said it will no longer be able to sell its chikungunya vaccine in the U.S. after reports linked the vaccine to adverse effects. Shares trading in New York were nearly 22% lower ahead of the morning bell at $9.09.

BioPharma Dive · 11h

FDA suspends license for Valneva’s chikungunya shot

The agency said it had become aware of more reports of serious adverse events, leading center director Vinay Prasad to conclude the vaccine is no longer safe for its intended use.

FDA Pulls Valneva’s Chikungunya Shot From Market Citing ‘Serious Safety Concerns’

Earlier this month, the FDA backed off on a pause in shipments of the chikungunya vaccine Ixchiq to older adults. Now, the ...

23hon MSN

FDA suspends Valneva's chikungunya vaccine license in the U.S

The United States Food and Drug Administration (FDA) has suspended the license for Valneva's chikungunya vaccine Ixchiq with ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results